Streetbeat News

Stock Prices

MYRG

MYR Group (NASDAQ:MYRG) is expected to report an EPS of $1.50 in its upcoming quarterly earnings on 2024-02-28. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows a mixed reaction to past earnings, with share price movements varying significantly post-earnings announcement. Shares are currently trading at $163.87, reflecting a 36.26% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

PAYO

Payoneer Global (NASDAQ:PAYO) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.06. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed earnings performance and a general negative trend in stock price over the last year, with shares down 15.98%.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

FL

Foot Locker (NYSE:FL) has been analyzed by 7 analysts, showing a shift towards a more bearish outlook in the last 30 days with an increase in bearish ratings and a significant rise in the average price target to $27.0 from $22.43. Analysts from firms like Citigroup, Piper Sandler, Morgan Stanley, Goldman Sachs, and Telsey Advisory Group have adjusted their ratings and price targets, reflecting dynamic market conditions and Foot Locker's performance. Despite these adjustments, Foot Locker faces challenges in revenue growth, net margin, ROE, ROA, and debt management, indicating potential difficulties in maintaining profitability and efficient capital utilization.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

KYMR

Piper Sandler has maintained its Overweight rating on Kymera Therapeutics (NASDAQ:KYMR) and increased its price target from $39.00 to $56.00. Kymera's shares are slightly down by 0.07% at $43.41. The new price target suggests a potential 29.0% increase. Kymera is a biotech company focused on targeted protein degradation to treat diseases with its Pegasus platform.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

ACHR

Cantor Fitzgerald has reaffirmed its Overweight rating on Archer Aviation (NYSE:ACHR) and maintained its price target at $10.00, despite the stock currently trading at $4.77, down 3.05% over the last 24 hours. The firm's target implies a potential upside of 109.64%. Archer Aviation is focused on developing sustainable air mobility solutions, including a fully electric vertical takeoff and landing aircraft designed for urban transportation.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

SPLK

Splunk's (NYSE:SPLK) short interest has increased by 14.23% since the last report, with 4.99 million shares sold short, representing 2.97% of its float. This indicates a bearish market sentiment towards SPLK, although it has less short interest compared to its peers' average of 3.00%. The article suggests that an increase in short interest does not necessarily predict a near-term price fall.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

CHRD

Chord Energy (NYSE:CHRD) has seen a 13.16% increase in short interest since its last report, with 2.01 million shares sold short, representing 4.9% of its float. This indicates a bearish market sentiment, although it's below the peer group average of 6.28%. The article suggests that an increase in short interest doesn't necessarily predict a stock price fall.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

UNP

Over the past 20 years, Union Pacific (NYSE:UNP) has produced an average annual return of 15.05%, outperforming the market by 7.43% annually. With a current market capitalization of $155.64 billion, a $100 investment in UNP 20 years ago would now be worth $1,667.42. This showcases the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

VMI

DA Davidson has maintained its Buy rating for Valmont Industries (NYSE:VMI) but lowered its price target from $290.00 to $275.00. Despite this adjustment, the new target suggests a potential 28.06% increase from the current share price of $214.75. Valmont Industries operates primarily in the Infrastructure and Agriculture segments, with the majority of its revenue derived from North America.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm

CME

Over the past 20 years, CME Group (NASDAQ:CME) has produced an average annual return of 12.86%, outperforming the market by 5.24% on an annualized basis. A $100 investment in CME stock 20 years ago would be worth $1,149.58 today. CME Group currently has a market capitalization of $78.74 billion, highlighting the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:00 pm